Updates in the Metabolic Management of Calcium Stones

[1] López M(2010)History, epidemiology and regional diversities of urolithiasis Pediatr Nephrol 25 49-59

[2] Hoppe B(2016)Do stones still kill? An analysis of death from stone disease 1999–2013 in England and Wales BJU Int 118 140-144

[3] Kum F(2012)Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics Urology 79 1286-1289

[4] Mahmalji W(2011)Oral antibiotic treatment of helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes J Endourol 25 1781-1785

[5] Hale J(2016)Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement J Nephrol 29 715-734

[6] Thomas K(2015)Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines Eur Urol 67 750-763

[7] Bultitude M(2015)Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group Arch Ital Urol Androl 87 105-120

[8] Glass J(2014)Medical management of kidney stones: AUA guidelines J Urol 192 316-324

[9] Lange JN(2016)Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers Urolithiasis 44 399-407

[10] Wood KD(2016)Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures Sci Rep 6 34712-2410

[1] López M(2010)History, epidemiology and regional diversities of urolithiasis Pediatr Nephrol 25 49-59

[2] Hoppe B(2016)Do stones still kill? An analysis of death from stone disease 1999–2013 in England and Wales BJU Int 118 140-144

[3] Kum F(2012)Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics Urology 79 1286-1289

[4] Mahmalji W(2011)Oral antibiotic treatment of helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes J Endourol 25 1781-1785

[5] Hale J(2016)Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement J Nephrol 29 715-734

[6] Thomas K(2015)Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines Eur Urol 67 750-763

[7] Bultitude M(2015)Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group Arch Ital Urol Androl 87 105-120

[8] Glass J(2014)Medical management of kidney stones: AUA guidelines J Urol 192 316-324

[9] Lange JN(2016)Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers Urolithiasis 44 399-407

[10] Wood KD(2016)Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures Sci Rep 6 34712-2410